ブログ · 最新・日付付き・出典明記
GLP-1、今——2026年に何が変わり、データは何を示しているか。
今年実際に検索されている質問に、まず結論から答える解説記事。いずれもFDAの処方情報と査読済み臨床試験に基づいています。普遍的な基礎知識については、まずGLP-1ガイドをご覧ください。
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
教育的なコンテンツであり、医療アドバイスではありません。各記事はFDAの処方情報と引用された臨床試験から作成されています。作成・更新方法については編集ポリシーをご覧ください。